His friend Gary Brecka, who calls himself the Ultimate Human, has backed Sermorelin and the CJC-1295 and Ipamorelin combination
Well look at the differences between these methods
Serum biomarkers like B12 or methylmalonic acid are not entirely useful in assessing or monitoring clinical improvement, and injection frequency should not be based on biomarker levels
No claims regarding human therapeutic outcomes are made or implied
For randomised clinical trials, the Jadad scale ( To complement the Jadad score, the Cochrane Risk of Bias Tool (RoB 2) (Sterne et al., 2019) was also used for RCTs to provide a domain-based qualitative evaluation, assessing risks related to selection, performance, detection, attrition, and reporting
Programs that skip those steps are not running a clinical pathway, regardless of how the marketing reads